Navigation Links
New European collaboration on cancer research
Date:1/19/2011

Europe's leading oncology organisations are combining forces in the global fight against cancer. The project, EurocanPlatform, has received 12 million from the European Union to streamline cross border research. The project will find more effective ways to ensure the prevention, early discovery and treatment of different forms of cancer.

Professor Ulrik Ringborg from the Swedish medical university Karolinska Institutet, who is coordinating the project, comments, "In a way, you could say that this initiative represents a paradigm shift in cancer research. The project will last for five years, establishing a collaborative structure within the EU for cancer research."

Despite improved diagnostics and treatment in recent years, the number of people dying of cancer is expected to rise. Already the world's deadliest disease group, cancer is growing as one of the largest chronic diseases, putting immense pressure on healthcare systems around the globe.

At the same time, however, modern cancer research is rapidly improving understanding of the disease, and new technologies are being developed for use in patient focused cancer research. Scientists hope that they will one day not only be able to identify people at risk for cancer, but also adapt therapies to different types of cancer and to patients' individual circumstances.

"An important part of the project involves getting the right therapy to the right patient at the right time," says Professor Ringborg. "But before we can get there, we need to do a great deal of research since the range of possible tumours and therapies is vast. No one research centre can have the resources needed. We must make sure that we coordinate and exploit the resources we have to the full."

EurocanPlatform is a network of Europe's 28 most research-intensive institutions in the field of cancer, of which the majority are clinical (patient focused), the remainder being engaged in basic research. A great many researchers from Sweden, Denmark, Norway, France, Spain, Italy, Germany, Hungary, the Netherlands, Belgium, and Britain are involved in various parts of the project. The collaborative platform allows individual research groups and organisations to conduct studies they would not otherwise have the resources for; with the costs of expensive equipment, tumour material and competence shared.

"The ultimate winners will be the patients, the public and the healthcare services." adds Professor Ringborg.

EurocanPlatform is due to hold its first conference in Stockholm on 20 January 2011. The project has gained funding under the EU's Seventh Framework Programme and is classed as a Network of Excellence (NoE).

Below is a list of the EurocanPlatform partners:

  1. Karolinska Institutet ("Coordinator"), Sweden
  2. Institut Curie, France
  3. Danish Cancer Society, Denmark
  4. Oslo Comprehensive Cancer Centre, Norway
  5. Spanish National Cancer Centre, Spain
  6. Istituto Nazionale dei Tumori, Italy
  7. German Cancer Research Centre, Germany
  8. Institut Gustave Roussy, France
  9. International Agency for Research on Cancer, France
  10. University of Oxford, UK
  11. European Institute of Oncology, Italy
  12. Christie NHS Foundation Trust, UK
  13. National Institute of Oncology, Hungary
  14. Netherlands Cancer Institute, Netherlands
  15. Erasmus Medical Centre, Netherlands
  16. Cambridge Cancer Research Institute, UK
  17. Institut Jules Bordet, Belgium
  18. European Molecular Biology Laboratory, Germany
  19. Institute of Cancer Research, Royal Marsden Hospital, UK
  20. Leiden University Medical Centre, Netherlands
  21. Fundacion Instituto Valenciano de Oncologia, Spain
  22. Istituto Tumori Bari, Italy
  23. Fundacio Privada Institut d'Investigacio Oncologica de Vall Hebron, Spain
  24. eCancer.eu, Switzerland
  25. ECCO The European CanCer Organisation, Belgium
  26. Organisation of European Cancer Institutes, Belgium
  27. European Cancer Patient Coalition, Netherlands
  28. European Organisation for Research and Treatment of Cancer, Belgium


'/>"/>

Contact: KI Press Office
pressinfo@ki.se
46-852-486-077
Karolinska Institutet
Source:Eurekalert

Related medicine news :

1. European Research Council awards advanced researcher grant to KIT botanist Holger Puchta
2. European Multidisciplinary Conference in Thoracic Oncology
3. Chronic Disease Alliance receives European Health Award 2010
4. European Nurse Society calls to action on breakthrough cancer pain
5. Heart, kidney, diabetes and cancer MEP groups league against chronic disease to seek European commitment
6. European Researchers Find Genes Tied to Asthma
7. European partnership funds research toward robot aides for the elderly
8. New case series section in European Urology
9. European Society of Cardiology launches heart-friendly cookery book
10. New impact factor of European Urology underlines journals outstanding position
11. European patient survey add weight to expert call for greater clinical consensus on BTCP
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... City trips ... (IBT World Travel Trends Report). As travelers visit both urban destinations, they are ... and prolonged sun exposure. In response, the outdoor industry has blurred the lines ...
(Date:3/28/2017)... ... March 28, 2017 , ... Z-Medica, LLC, ... of Pittsburgh Medical Center (UPMC) will acquire QuikClot® Bleeding Control Kits® (BCK) to ... developed in association with efforts by the American College of Surgeons, U.S. Department ...
(Date:3/28/2017)... Calif. (PRWEB) , ... March 28, 2017 , ... ... its leading physicians, Paul Yost, will begin serving as new board chair for ... this month. Yost will serve the remainder of soon-to-be former chair Mark Refowitz’s ...
(Date:3/28/2017)... ... March 28, 2017 , ... In ... Self-Funding Success website has recently developed and published an informational resource that addresses ... created based on common inquiries the site’s team of third party administrator (TPA) ...
(Date:3/28/2017)... ... March 28, 2017 , ... Prominant bariatric surgeon and well-known ... to offer the recently FDA-approved Obalon Balloon System to his patients. The Obalon ... Surgical’s already comprehensive list of weight-loss services. Dr. Liu is proud to ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... 2017  Akcea Therapeutics, a subsidiary of Ionis Pharmaceuticals, Inc. ... of directors: Christopher Gabrieli ... serve as chairman of the board of Akcea Therapeutics. ... of Forest Laboratories. Sandford D. Smith ... "We are excited to announce this expansion to ...
(Date:3/28/2017)... , March 28, 2017 ... expected to reach a value of USD 4.5 billion ... View Research, Inc. Proper closure of injured tissues post ... and function. Postoperative leakages occur in 3% to 15% ... They are responsible for one third of postoperative deaths ...
(Date:3/27/2017)... , March 27, 2017 The National ... health and data analytics company, signed a Memorandum ... improving healthcare delivery in the region. ... Global Health Research and Technology (BIGHEART) at NUS ... several topics related to healthcare IT and medical ...
Breaking Medicine Technology: